PDA Draft Technical Report No. 29 - Pharmanet

← Back to document page

PDA Technical Report No. 29Points to Consider forCleaning ValidationDRAFTMarch 30, Pharmaceutical Cleaning Validation Task ForceJames P. Agalloco, Agalloco & AssociatesWill Brame, Rhone-Poulenc RorerBohdan Ferenc, Novartis Pharmaceuticals E. Hall, , Hall & AssociatesKevin Jenkins, Pharmacia & Uphohn, T. LaMagna, Pfizer, E. Madsen, PDA (Chairman)Michael V. Mullen, , Eli Lilly and CompanyDietmar Wagenknecht, Fujisawa USA, M. Wagner, , Wyeth-Lederle Vaccines & PediatricsiiPrefaceThis document provides guidance relative to the validation of cleaning for a broad range of processingsystems and product types within the pharmaceutical industry. This effort commenced in 1991 inconjunction with individuals representing the biotechnology community.

PDA Technical Report No. 29 Points to Consider for Cleaning Validation DRAFT March 30, 1998 TR28_002.PDF

  Draft, Report, Technical, Technical report, Pda draft technical report no